Influence of body mass index on the association of weight changes with mortality in hemodialysis patients

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F13%3A00058694" target="_blank" >RIV/00023001:_____/13:00058694 - isvavai.cz</a>

Výsledek na webu

<a href="http://cjasn.asnjournals.org/content/8/10/1725.full.pdf+html" target="_blank" >http://cjasn.asnjournals.org/content/8/10/1725.full.pdf+html</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2215/CJN.10951012" target="_blank" >10.2215/CJN.10951012</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Influence of body mass index on the association of weight changes with mortality in hemodialysis patients

Popis výsledku v původním jazyce

Background and ObjectivesA high body mass index (BMI) is associated with lower mortality in patients undergoing hemodialysis. Short-term weight gains and losses are also related to lower and higher mortality risk, respectively. The implications of weightgain or loss may, however, differ between obese individuals and their nonobese counterparts.Design, Setting, Participants, & MeasurementsThe Current Management of Secondary Hyperparathyroidism: A Multicenter Observational Study (COSMOS) is an observational study including 6797 European hemodialysis patients recruited between February 2005 and July 2007, with prospective data collection every 6 months for 3 years. Time-dependent Cox proportional hazard regressions assessed the effect of BMI and weight changes on mortality. Analyses were performed after patient stratification according to their starting BMI.ResultsAmong 6296 patients with complete data, 1643 died. At study entry, 42% of patients had a normal weight (BMI, 20-25 kg/m(2)),

Název v anglickém jazyce

Influence of body mass index on the association of weight changes with mortality in hemodialysis patients

Popis výsledku anglicky

Background and ObjectivesA high body mass index (BMI) is associated with lower mortality in patients undergoing hemodialysis. Short-term weight gains and losses are also related to lower and higher mortality risk, respectively. The implications of weightgain or loss may, however, differ between obese individuals and their nonobese counterparts.Design, Setting, Participants, & MeasurementsThe Current Management of Secondary Hyperparathyroidism: A Multicenter Observational Study (COSMOS) is an observational study including 6797 European hemodialysis patients recruited between February 2005 and July 2007, with prospective data collection every 6 months for 3 years. Time-dependent Cox proportional hazard regressions assessed the effect of BMI and weight changes on mortality. Analyses were performed after patient stratification according to their starting BMI.ResultsAmong 6296 patients with complete data, 1643 died. At study entry, 42% of patients had a normal weight (BMI, 20-25 kg/m(2)),

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FP - Ostatní lékařské obory

OECD FORD obor

—

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Clinical journal of the American Society of Nephrology

ISSN

1555-9041

e-ISSN

—

Svazek periodika

8

Číslo periodika v rámci svazku

10

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

9

Strana od-do

1725-1733

Kód UT WoS článku

000325268200014

EID výsledku v databázi Scopus

—